The approval by the health ministry of three medicines and the research in the cultivation of chondrocytes makes BIOIBERICA FARMA the Spanish pharmaceutical company with the widest range of products for arthrosis treatment.

In order to cater to the growing number of arthrosis patients, a sales network covering the entire national territory has been created, with some 50 medical representatives distributed among four main areas, each of them supervised by an area manager.

This sales network, which Intends to reach 3500 traumatologists, 800 rheumatologists and 500 rehabilitationists, offers medical doctors specific information on joint protection with ample technical support.

BIOIBERICA FARMA is the only laboratory researching, as well as producing, the widest range of options in joint protection.